{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:15Z","timestamp":1786982115785,"version":"build-2736575974"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK119506"],"award-info":[{"award-number":["DK119506"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["1298617"],"award-info":[{"award-number":["1298617"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11883-025-01321-y","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:03:43Z","timestamp":1754550223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Weixiong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"4","key":"1321_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U Forstermann","year":"2017","unstructured":"Forstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713\u201335.","journal-title":"Circ Res"},{"key":"1321_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.biopha.2017.10.122","volume":"97","author":"JY Chen","year":"2018","unstructured":"Chen JY, et al. Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed Pharmacother. 2018;97:423\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"1321_CR3","doi-asserted-by":"publisher","first-page":"15200","DOI":"10.3390\/ijms242015200","volume":"24","author":"R Roy","year":"2023","unstructured":"Roy R, et al. Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int J Mol Sci. 2023;24(20):15200.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI8376","volume":"105","author":"JW Knowles","year":"2000","unstructured":"Knowles JW, et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-\/-)Apoe(-\/-) mice are ameliorated by enalapril treatment. J Clin Invest. 2000;105(4):451\u20138.","journal-title":"J Clin Invest"},{"issue":"4","key":"1321_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/hc2901.091399","volume":"104","author":"PJ Kuhlencordt","year":"2001","unstructured":"Kuhlencordt PJ, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E\/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104(4):448\u201354.","journal-title":"Circulation"},{"issue":"5","key":"1321_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. 2018;15(5):292\u2013316.","journal-title":"Nat Rev Cardiol"},{"issue":"6546","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/377239a0","volume":"377","author":"PL Huang","year":"1995","unstructured":"Huang PL, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377(6546):239\u201342.","journal-title":"Nature"},{"issue":"6","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","volume":"88","author":"MT Johnstone","year":"1993","unstructured":"Johnstone MT, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88(6):2510\u20136.","journal-title":"Circulation"},{"issue":"5","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2337\/diabetes.49.5.684","volume":"49","author":"RR Shankar","year":"2000","unstructured":"Shankar RR, et al. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes. 2000;49(5):684\u20137.","journal-title":"Diabetes"},{"key":"1321_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.biopha.2017.06.036","volume":"93","author":"M Lind","year":"2017","unstructured":"Lind M, et al. Inducible nitric oxide synthase: Good or bad? Biomed Pharmacother. 2017;93:370\u20135.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1321_CR11","first-page":"19","volume":"77","author":"VW Liu","year":"2008","unstructured":"Liu VW, Huang PL. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res. 2008;77(1):19\u201329.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"1321_CR12","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1161\/01.ATV.19.11.2584","volume":"19","author":"PM Schwarz","year":"1999","unstructured":"Schwarz PM, Kleinert H, Forstermann U. Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. Arterioscler Thromb Vasc Biol. 1999;19(11):2584\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2009.02.033","volume":"206","author":"J Schodel","year":"2009","unstructured":"Schodel J, et al. Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice. Atherosclerosis. 2009;206(2):383\u20139.","journal-title":"Atherosclerosis"},{"issue":"15","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.107.744540","volume":"117","author":"MD Seddon","year":"2008","unstructured":"Seddon MD, et al. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation. 2008;117(15):1991\u20136.","journal-title":"Circulation"},{"issue":"20","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1161\/CIRCULATIONAHA.108.822205","volume":"119","author":"M Seddon","year":"2009","unstructured":"Seddon M, et al. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation. 2009;119(20):2656\u201362.","journal-title":"Circulation"},{"issue":"7","key":"1321_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.ATV.0000223143.88128.19","volume":"26","author":"PJ Kuhlencordt","year":"2006","unstructured":"Kuhlencordt PJ, et al. Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol. 2006;26(7):1539\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00424-009-0767-7","volume":"459","author":"I Fleming","year":"2010","unstructured":"Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 2010;459(6):793\u2013806.","journal-title":"Pflugers Arch"},{"issue":"2","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015;129(2):83\u201394.","journal-title":"J Pharmacol Sci"},{"issue":"Suppl","key":"1321_CR19","first-page":"59","volume":"57","author":"V Randriamboavonjy","year":"2005","unstructured":"Randriamboavonjy V, Fleming I. Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there? Pharmacol Rep. 2005;57(Suppl):59\u201365.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1321_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1152\/physiolgenomics.2001.5.1.35","volume":"5","author":"RW Grange","year":"2001","unstructured":"Grange RW, et al. Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles. Physiol Genomics. 2001;5(1):35\u201344.","journal-title":"Physiol Genomics"},{"issue":"5","key":"1321_CR21","doi-asserted-by":"publisher","first-page":"H1233","DOI":"10.1152\/ajpheart.00737.2019","volume":"318","author":"AJA Leloup","year":"2020","unstructured":"Leloup AJA, et al. Ex vivo aortic stiffness in mice with different eNOS activity. Am J Physiol Heart Circ Physiol. 2020;318(5):H1233\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","volume":"88","author":"P Kubes","year":"1991","unstructured":"Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88(11):4651\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1321_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/0016-5085(94)90229-1","volume":"107","author":"KL Davenpeck","year":"1994","unstructured":"Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 1994;107(4):1050\u20138.","journal-title":"Gastroenterology"},{"issue":"6","key":"1321_CR24","first-page":"H1943","volume":"276","author":"DJ Lefer","year":"1999","unstructured":"Lefer DJ, et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol. 1999;276(6):H1943\u201350.","journal-title":"Am J Physiol"},{"issue":"1","key":"1321_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1476-9255-9-28","volume":"9","author":"M Hossain","year":"2012","unstructured":"Hossain M, Qadri SM, Liu L. Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. J Inflamm (Lond). 2012;9(1):28.","journal-title":"J Inflamm (Lond)"},{"key":"1321_CR26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fphys.2017.01124","volume":"8","author":"F Gao","year":"2017","unstructured":"Gao F, et al. Reduction of endothelial nitric oxide increases the adhesiveness of constitutive endothelial membrane ICAM-1 through Src-mediated phosphorylation. Front Physiol. 2017;8:1124.","journal-title":"Front Physiol"},{"issue":"20","key":"1321_CR27","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/hc4501.099729","volume":"104","author":"J Chen","year":"2001","unstructured":"Chen J, et al. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e\/endothelial nitric oxide synthase double knockout mice. Circulation. 2001;104(20):2391\u20134.","journal-title":"Circulation"},{"issue":"2","key":"1321_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.niox.2010.04.007","volume":"23","author":"A Pautz","year":"2010","unstructured":"Pautz A, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23(2):75\u201393.","journal-title":"Nitric Oxide"},{"issue":"6","key":"1321_CR29","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1253\/circj.CJ-09-0208","volume":"73","author":"M Tsutsui","year":"2009","unstructured":"Tsutsui M, et al. Nitric oxide synthases and cardiovascular diseases: insights from genetically modified mice. Circ J. 2009;73(6):986\u201393.","journal-title":"Circ J"},{"issue":"1","key":"1321_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0008-6363(03)00389-4","volume":"60","author":"BB Chesebro","year":"2003","unstructured":"Chesebro BB, et al. Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis. Cardiovasc Res. 2003;60(1):170\u20134.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1321_CR31","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.4049\/jimmunol.165.6.3430","volume":"165","author":"PA Detmers","year":"2000","unstructured":"Detmers PA, et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol. 2000;165(6):3430\u20135.","journal-title":"J Immunol"},{"issue":"13","key":"1321_CR32","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1073\/pnas.94.13.6954","volume":"94","author":"Y Xia","year":"1997","unstructured":"Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A. 1997;94(13):6954\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1321_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0008-6363(98)00304-6","volume":"41","author":"C Depre","year":"1999","unstructured":"Depre C, et al. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res. 1999;41(2):465\u201372.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1321_CR34","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.2353\/ajpath.2009.080730","volume":"174","author":"P Ponnuswamy","year":"2009","unstructured":"Ponnuswamy P, et al. Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase. Am J Pathol. 2009;174(6):2400\u201310.","journal-title":"Am J Pathol"},{"issue":"8","key":"1321_CR35","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/01.ATV.0000172626.00296.ba","volume":"25","author":"CA Gunnett","year":"2005","unstructured":"Gunnett CA, et al. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler Thromb Vasc Biol. 2005;25(8):1617\u201322.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1321_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.niox.2018.03.019","volume":"76","author":"J Wobst","year":"2018","unstructured":"Wobst J, Schunkert H, Kessler T. Genetic alterations in the NO-cGMP pathway and cardiovascular risk. Nitric Oxide. 2018;76:105\u201312.","journal-title":"Nitric Oxide"},{"issue":"6","key":"1321_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/FJC.0000000000000744","volume":"75","author":"TA Dang","year":"2020","unstructured":"Dang TA, Schunkert H, Kessler T. cGMP signaling in cardiovascular diseases: linking genotype and phenotype. J Cardiovasc Pharmacol. 2020;75(6):516\u201325.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1321_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00109-015-1265-3","volume":"93","author":"J Wobst","year":"2015","unstructured":"Wobst J, et al. Role of sGC-dependent NO signalling and myocardial infarction risk. J Mol Med (Berl). 2015;93(4):383\u201394.","journal-title":"J Mol Med (Berl)"},{"key":"1321_CR39","doi-asserted-by":"publisher","first-page":"617366","DOI":"10.3389\/fcell.2021.617366","volume":"9","author":"S Li","year":"2021","unstructured":"Li S, et al. pCysMod: prediction of multiple cysteine modifications based on deep learning framework. Front Cell Dev Biol. 2021;9:617366.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"1321_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/genes5020254","volume":"5","author":"A Abunimer","year":"2014","unstructured":"Abunimer A, et al. Single-nucleotide variations in cardiac arrhythmias: prospects for genomics and proteomics based biomarker discovery and diagnostics. Genes (Basel). 2014;5(2):254\u201369.","journal-title":"Genes (Basel)"},{"issue":"2","key":"1321_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrm1569","volume":"6","author":"DT Hess","year":"2005","unstructured":"Hess DT, et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6(2):150\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1321_CR42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.molcel.2017.12.025","volume":"69","author":"D Seth","year":"2018","unstructured":"Seth D, et al. A multiplex enzymatic machinery for cellular protein S-nitrosylation. Mol Cell. 2018;69(3):451\u201364.","journal-title":"Mol Cell"},{"issue":"10","key":"1321_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1089\/ars.2017.7403","volume":"30","author":"CT Stomberski","year":"2019","unstructured":"Stomberski CT, Hess DT, Stamler JS. Protein S-Nitrosylation: determinants of specificity and enzymatic regulation of S-Nitrosothiol-based signaling. Antioxid Redox Signal. 2019;30(10):1331\u201351.","journal-title":"Antioxid Redox Signal"},{"issue":"32","key":"1321_CR44","doi-asserted-by":"publisher","first-page":"21890","DOI":"10.1074\/jbc.M801047200","volume":"283","author":"SI Hashemy","year":"2008","unstructured":"Hashemy SI, Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem. 2008;283(32):21890\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"1321_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2014.09.032","volume":"159","author":"J Jia","year":"2014","unstructured":"Jia J, et al. Target-selective protein S-nitrosylation by sequence motif recognition. Cell. 2014;159(3):623\u201334.","journal-title":"Cell"},{"issue":"11","key":"1321_CR46","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ncb2114","volume":"12","author":"MD Kornberg","year":"2010","unstructured":"Kornberg MD, et al. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol. 2010;12(11):1094\u2013100.","journal-title":"Nat Cell Biol"},{"issue":"6820","key":"1321_CR47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/35054560","volume":"409","author":"JR Pawloski","year":"2001","unstructured":"Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409(6820):622\u20136.","journal-title":"Nature"},{"issue":"6","key":"1321_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0092-8674(01)00495-0","volume":"106","author":"JS Stamler","year":"2001","unstructured":"Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 2001;106(6):675\u201383.","journal-title":"Cell"},{"issue":"26","key":"1321_CR49","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1016\/j.cell.2023.11.009","volume":"186","author":"HL Zhou","year":"2023","unstructured":"Zhou HL, et al. An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling. Cell. 2023;186(26):5812\u201325.","journal-title":"Cell"},{"issue":"7737","key":"1321_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-018-0749-z","volume":"565","author":"HL Zhou","year":"2019","unstructured":"Zhou HL, et al. Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury. Nature. 2019;565(7737):96\u2013100.","journal-title":"Nature"},{"issue":"6827","key":"1321_CR51","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/35068596","volume":"410","author":"L Liu","year":"2001","unstructured":"Liu L, et al. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410(6827):490\u20134.","journal-title":"Nature"},{"issue":"5879","key":"1321_CR52","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1126\/science.1158265","volume":"320","author":"M Benhar","year":"2008","unstructured":"Benhar M, et al. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science. 2008;320(5879):1050\u20134.","journal-title":"Science"},{"key":"1321_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/srep00139","volume":"1","author":"M Dashti","year":"2011","unstructured":"Dashti M, et al. A phospholipidomic analysis of all defined human plasma lipoproteins. Sci Rep. 2011;1:139.","journal-title":"Sci Rep"},{"issue":"1","key":"1321_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan Y, et al. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther. 2022;7(1):265.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1321_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1321_CR56","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res. 2009;50:S183-8.","journal-title":"J Lipid Res"},{"issue":"3","key":"1321_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron"},{"issue":"1","key":"1321_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajpa.21298","volume":"143","author":"DT Eisenberg","year":"2010","unstructured":"Eisenberg DT, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol. 2010;143(1):100\u201311.","journal-title":"Am J Phys Anthropol"},{"issue":"2","key":"1321_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68(2):270\u201381.","journal-title":"Neuron"},{"issue":"17","key":"1321_CR60","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1021\/bi200266v","volume":"50","author":"AJ Abrams","year":"2011","unstructured":"Abrams AJ, Farooq A, Wang G. S-nitrosylation of ApoE in Alzheimer\u2019s disease. Biochemistry. 2011;50(17):3405\u20137.","journal-title":"Biochemistry"},{"issue":"2","key":"1321_CR61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1124\/pr.107.08002","volume":"60","author":"VM Miller","year":"2008","unstructured":"Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60(2):210\u201341.","journal-title":"Pharmacol Rev"},{"issue":"46","key":"1321_CR62","doi-asserted-by":"publisher","first-page":"44044","DOI":"10.1074\/jbc.M208539200","volume":"277","author":"G He","year":"2002","unstructured":"He G, et al. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2. J Biol Chem. 2002;277(46):44044\u20139.","journal-title":"J Biol Chem"},{"issue":"25","key":"1321_CR63","doi-asserted-by":"publisher","first-page":"16099","DOI":"10.1073\/pnas.252630799","volume":"99","author":"SK Mishra","year":"2002","unstructured":"Mishra SK, Watkins SC, Traub LM. The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery. Proc Natl Acad Sci U S A. 2002;99(25):16099\u2013104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"1321_CR64","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1073\/pnas.1114128109","volume":"109","author":"H Dvir","year":"2012","unstructured":"Dvir H, et al. Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail. Proc Natl Acad Sci U S A. 2012;109(18):6916\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"1321_CR65","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1093\/emboj\/cdf487","volume":"21","author":"SK Mishra","year":"2002","unstructured":"Mishra SK, et al. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J. 2002;21(18):4915\u201326.","journal-title":"EMBO J"},{"issue":"6","key":"1321_CR66","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1194\/jlr.M033167","volume":"54","author":"Z Zhao","year":"2013","unstructured":"Zhao Z, et al. S-nitrosylation of ARH is required for LDL uptake by the LDL receptor. J Lipid Res. 2013;54(6):1550\u20139.","journal-title":"J Lipid Res"},{"issue":"12","key":"1321_CR67","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264\u201372.","journal-title":"N Engl J Med"},{"issue":"4","key":"1321_CR68","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/humu.20882","volume":"30","author":"M Abifadel","year":"2009","unstructured":"Abifadel M, et al. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease. Hum Mutat. 2009;30(4):520\u20139.","journal-title":"Hum Mutat"},{"key":"1321_CR69","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","volume":"50","author":"JD Horton","year":"2009","unstructured":"Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009;50:S172-7.","journal-title":"J Lipid Res"},{"issue":"4","key":"1321_CR70","doi-asserted-by":"publisher","first-page":"111538","DOI":"10.1016\/j.celrep.2022.111538","volume":"41","author":"CT Stomberski","year":"2022","unstructured":"Stomberski CT, et al. A multienzyme S-nitrosylation cascade regulates cholesterol homeostasis. Cell Rep. 2022;41(4):111538.","journal-title":"Cell Rep"},{"issue":"50","key":"1321_CR71","doi-asserted-by":"publisher","first-page":"48803","DOI":"10.1074\/jbc.M209477200","volume":"277","author":"R van Haperen","year":"2002","unstructured":"van Haperen R, et al. Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. J Biol Chem. 2002;277(50):48803\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"1321_CR72","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1373\/clinchem.2007.093575","volume":"54","author":"R Maas","year":"2008","unstructured":"Maas R, et al. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clin Chem. 2008;54(2):292\u2013300.","journal-title":"Clin Chem"},{"issue":"4","key":"1321_CR73","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84(4):1381\u2013478.","journal-title":"Physiol Rev"},{"issue":"12","key":"1321_CR74","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.freeradbiomed.2009.09.009","volume":"47","author":"JA Leopold","year":"2009","unstructured":"Leopold JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med. 2009;47(12):1673\u2013706.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1321_CR75","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bbadis.2018.02.009","volume":"1865","author":"W Wang","year":"2019","unstructured":"Wang W, et al. eNOS S-nitrosylation mediated OxLDL-induced endothelial dysfunction via increasing the interaction of eNOS with beta-catenin. Biochim Biophys Acta Mol Basis Dis. 2019;1865(7):1793\u2013801.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1321_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jprot.2019.01.001","volume":"195","author":"X Xu","year":"2019","unstructured":"Xu X, et al. The protein S-nitrosylation of splicing and translational machinery in vascular endothelial cells is susceptible to oxidative stress induced by oxidized low-density lipoprotein. J Proteomics. 2019;195:11\u201322.","journal-title":"J Proteomics"},{"issue":"5","key":"1321_CR77","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jvs.2010.04.085","volume":"52","author":"WJ Lee","year":"2010","unstructured":"Lee WJ, et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg. 2010;52(5):1290\u2013300.","journal-title":"J Vasc Surg"},{"issue":"8","key":"1321_CR78","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1073\/pnas.0300464101","volume":"101","author":"K Ravi","year":"2004","unstructured":"Ravi K, et al. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci U S A. 2004;101(8):2619\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"1321_CR79","doi-asserted-by":"publisher","first-page":"19888","DOI":"10.1074\/jbc.M413058200","volume":"280","author":"PA Erwin","year":"2005","unstructured":"Erwin PA, et al. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem. 2005;280(20):19888\u201394.","journal-title":"J Biol Chem"},{"issue":"1","key":"1321_CR80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1074\/jbc.M510421200","volume":"281","author":"PA Erwin","year":"2006","unstructured":"Erwin PA, et al. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem. 2006;281(1):151\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"1321_CR81","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MOL.0b013e32834aa701","volume":"22","author":"A Tsaousi","year":"2011","unstructured":"Tsaousi A, Mill C, George SJ. The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol. 2011;22(5):350\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"1321_CR82","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCRESAHA.107.166405","volume":"103","author":"A Bedel","year":"2008","unstructured":"Bedel A, et al. E-cadherin\/beta-catenin\/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res. 2008;103(7):694\u2013701.","journal-title":"Circ Res"},{"issue":"4","key":"1321_CR83","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cardiores.2004.11.003","volume":"65","author":"I Fleming","year":"2005","unstructured":"Fleming I, et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res. 2005;65(4):897\u2013906.","journal-title":"Cardiovasc Res"},{"issue":"24","key":"1321_CR84","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules25245980","volume":"25","author":"A Taler-Vercic","year":"2020","unstructured":"Taler-Vercic A, Golicnik M, Bavec A. The structure and function of paraoxonase-1 and its comparison to paraoxonase-2 and -3. Molecules. 2020;25(24):5980.","journal-title":"Molecules"},{"issue":"3","key":"1321_CR85","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/biof.1427","volume":"44","author":"L Dahli","year":"2018","unstructured":"Dahli L, et al. Lyso-DGTS lipid isolated from microalgae enhances PON1 activities in vitro and in vivo, increases PON1 penetration into macrophages and decreases cellular lipid accumulation. BioFactors. 2018;44(3):299\u2013310.","journal-title":"BioFactors"},{"issue":"7","key":"1321_CR86","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","volume":"26","author":"B Mackness","year":"2006","unstructured":"Mackness B, et al. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2006;26(7):1545\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1321_CR87","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2011.03.041","volume":"51","author":"H Tavori","year":"2011","unstructured":"Tavori H, et al. Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion. Free Radic Biol Med. 2011;51(1):234\u201342.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1321_CR88","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbrc.2014.01.042","volume":"444","author":"S Khatib","year":"2014","unstructured":"Khatib S, et al. The synthesis and analysis of S-nitorsylated paraoxonase 1. Biochem Biophys Res Commun. 2014;444(3):354\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1321_CR89","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/biom12030414","volume":"12","author":"H Hajouj","year":"2022","unstructured":"Hajouj H, et al. S-Nitrosylation of paraxonase 1 (PON1) elevates its hydrolytic and antioxidant activities. Biomolecules. 2022;12(3):414.","journal-title":"Biomolecules"},{"key":"1321_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","volume":"4","author":"AM Otto","year":"2016","unstructured":"Otto AM. Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 2016;4:5.","journal-title":"Cancer Metab"},{"issue":"7","key":"1321_CR91","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","volume":"43","author":"S Mazurek","year":"2011","unstructured":"Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2011;43(7):969\u201380.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1321_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0969-2126(98)00021-5","volume":"6","author":"MS Jurica","year":"1998","unstructured":"Jurica MS, et al. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure. 1998;6(2):195\u2013210.","journal-title":"Structure"},{"issue":"11","key":"1321_CR93","doi-asserted-by":"publisher","first-page":"e024854","DOI":"10.1161\/JAHA.121.024854","volume":"11","author":"L Ni","year":"2022","unstructured":"Ni L, et al. Pyruvate Kinase M2 protects heart from pressure overload-induced heart failure by phosphorylating RAC1. J Am Heart Assoc. 2022;11(11):e024854.","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"1321_CR94","doi-asserted-by":"publisher","first-page":"e100938","DOI":"10.15252\/embj.2018100938","volume":"38","author":"M Siragusa","year":"2019","unstructured":"Siragusa M, et al. Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition. EMBO J. 2019;38(17):e100938.","journal-title":"EMBO J"},{"issue":"10","key":"1321_CR95","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/s41401-024-01295-8","volume":"45","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Ren J. Endothelial dysfunction: mechanisms and contribution to diseases. Acta Pharmacol Sin. 2024;45(10):2023\u201331.","journal-title":"Acta Pharmacol Sin"},{"key":"1321_CR96","doi-asserted-by":"publisher","first-page":"787541","DOI":"10.3389\/fphar.2021.787541","volume":"12","author":"SR Botts","year":"2021","unstructured":"Botts SR, Fish JE, Howe KL. Dysfunctional vascular endothelium as a driver of atherosclerosis: emerging insights into pathogenesis and treatment. Front Pharmacol. 2021;12:787541.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1321_CR97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","volume":"16","author":"FH Brembeck","year":"2006","unstructured":"Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev. 2006;16(1):51\u20139.","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"1321_CR98","doi-asserted-by":"publisher","first-page":"C977","DOI":"10.1152\/ajpcell.90607.2007","volume":"294","author":"M Guo","year":"2008","unstructured":"Guo M, et al. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol Cell Physiol. 2008;294(4):C977\u201384.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1321_CR99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.05.024","volume":"133","author":"A Vallee","year":"2019","unstructured":"Vallee A, Vallee JN, Lecarpentier Y. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT\/beta-catenin pathway and PPARgamma. J Mol Cell Cardiol. 2019;133:36\u201346.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1321_CR100","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.molcel.2010.07.013","volume":"39","author":"S Thibeault","year":"2010","unstructured":"Thibeault S, et al. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell. 2010;39(3):468\u201376.","journal-title":"Mol Cell"},{"issue":"12","key":"1321_CR101","doi-asserted-by":"publisher","first-page":"e00089-17","DOI":"10.1128\/MCB.00089-17","volume":"37","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Endothelial NO synthase-dependent S-Nitrosylation of beta-catenin prevents its association with TCF4 and inhibits proliferation of endothelial cells stimulated by Wnt3a. Mol Cell Biol. 2017;37(12):e00089-17.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1321_CR102","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1074\/jbc.REV118.002806","volume":"294","author":"O Genest","year":"2019","unstructured":"Genest O, Wickner S, Doyle SM. Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling. J Biol Chem. 2019;294(6):2109\u201320.","journal-title":"J Biol Chem"},{"issue":"4","key":"1321_CR103","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0008-6363(01)00354-6","volume":"51","author":"DS Latchman","year":"2001","unstructured":"Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res. 2001;51(4):637\u201346.","journal-title":"Cardiovasc Res"},{"key":"1321_CR104","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yjmcc.2014.03.008","volume":"72","author":"J Kim","year":"2014","unstructured":"Kim J, et al. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis. J Mol Cell Cardiol. 2014;72:157\u201367.","journal-title":"J Mol Cell Cardiol"},{"issue":"23","key":"1321_CR105","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1111\/bph.15626","volume":"178","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Inhibition of HSP90 S-nitrosylation alleviates cardiac fibrosis via TGFbeta\/SMAD3 signalling pathway. Br J Pharmacol. 2021;178(23):4608\u201325.","journal-title":"Br J Pharmacol"},{"issue":"24","key":"1321_CR106","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.1073\/pnas.0407294102","volume":"102","author":"A Martinez-Ruiz","year":"2005","unstructured":"Martinez-Ruiz A, et al. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A. 2005;102(24):8525\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1321_CR107","doi-asserted-by":"publisher","first-page":"102290","DOI":"10.1016\/j.redox.2022.102290","volume":"52","author":"S Zhao","year":"2022","unstructured":"Zhao S, et al. Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosis. Redox Biol. 2022;52:102290.","journal-title":"Redox Biol"},{"issue":"10","key":"1321_CR108","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1161\/ATVBAHA.112.256008","volume":"32","author":"F Desjardins","year":"2012","unstructured":"Desjardins F, Delisle C, Gratton JP. Modulation of the cochaperone AHA1 regulates heat-shock protein 90 and endothelial NO synthase activation by vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2012;32(10):2484\u201392.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1321_CR109","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1097-2765(02)00450-1","volume":"9","author":"G Chen","year":"2002","unstructured":"Chen G, Cao P, Goeddel DV. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell. 2002;9(2):401\u201310.","journal-title":"Mol Cell"},{"issue":"44","key":"1321_CR110","doi-asserted-by":"publisher","first-page":"32311","DOI":"10.1074\/jbc.M705785200","volume":"282","author":"M Hinz","year":"2007","unstructured":"Hinz M, et al. Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90. J Biol Chem. 2007;282(44):32311\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"1321_CR111","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0592-85","volume":"1","author":"TM Wilkie","year":"1992","unstructured":"Wilkie TM, et al. Evolution of the mammalian G protein alpha subunit multigene family. Nat Genet. 1992;1(2):85\u201391.","journal-title":"Nat Genet"},{"key":"1321_CR112","first-page":"569654","volume":"2012","author":"SD Funk","year":"2012","unstructured":"Funk SD, Yurdagul A Jr, Orr AW. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med. 2012;2012:569654.","journal-title":"Int J Vasc Med"},{"issue":"5","key":"1321_CR113","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jcjd.2013.06.001","volume":"37","author":"MG Zeadin","year":"2013","unstructured":"Zeadin MG, Petlura CI, Werstuck GH. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis. Can J Diabetes. 2013;37(5):345\u201350.","journal-title":"Can J Diabetes"},{"issue":"1","key":"1321_CR114","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1038\/s41467-021-24736-y","volume":"12","author":"ML Chao","year":"2021","unstructured":"Chao ML, et al. S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo\/YAP-dependent diabetes-accelerated atherosclerosis. Nat Commun. 2021;12(1):4452.","journal-title":"Nat Commun"},{"issue":"4","key":"1321_CR115","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy P, Orecchioni M, Ley K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat Rev Immunol. 2022;22(4):251\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1321_CR116","doi-asserted-by":"publisher","first-page":"1685844","DOI":"10.1080\/21688370.2019.1685844","volume":"7","author":"FE Pulous","year":"2019","unstructured":"Pulous FE, Petrich BG. Integrin-dependent regulation of the endothelial barrier. Tissue Barriers. 2019;7(4):1685844.","journal-title":"Tissue Barriers"},{"issue":"12","key":"1321_CR117","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/CIRCRESAHA.112.278713","volume":"111","author":"F Suhr","year":"2012","unstructured":"Suhr F, Bloch W. Endothelial cell apoptosis: a new focal adhesion assembly makes the difference. Circ Res. 2012;111(12):1488\u201390.","journal-title":"Circ Res"},{"issue":"12","key":"1321_CR118","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00018-017-2490-4","volume":"74","author":"AC Finney","year":"2017","unstructured":"Finney AC, et al. Integrin signaling in atherosclerosis. Cell Mol Life Sci. 2017;74(12):2263\u201382.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1321_CR119","doi-asserted-by":"publisher","first-page":"102765","DOI":"10.1016\/j.jbc.2022.102765","volume":"299","author":"Q Yao","year":"2023","unstructured":"Yao Q, et al. Free fatty acids stabilize integrin beta(1)via S-nitrosylation to promote monocyte-endothelial adhesion. J Biol Chem. 2023;299(1):102765.","journal-title":"J Biol Chem"},{"issue":"17","key":"1321_CR120","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R Clarke","year":"1991","unstructured":"Clarke R, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324(17):1149\u201355.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1321_CR121","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","volume":"11","author":"RC Austin","year":"2004","unstructured":"Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(Suppl 1):S56-64.","journal-title":"Cell Death Differ"},{"key":"1321_CR122","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.biopha.2015.01.030","volume":"70","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation. Biomed Pharmacother. 2015;70:253\u20139.","journal-title":"Biomed Pharmacother"},{"key":"1321_CR123","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.redox.2018.04.021","volume":"17","author":"J Li","year":"2018","unstructured":"Li J, et al. GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation. Redox Biol. 2018;17:386\u201399.","journal-title":"Redox Biol"},{"key":"1321_CR124","doi-asserted-by":"publisher","first-page":"632378","DOI":"10.3389\/fphar.2021.632378","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. Role of PI3K in the Progression and Regression of Atherosclerosis. Front Pharmacol. 2021;12:632378.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1321_CR125","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1074\/jbc.M411871200","volume":"280","author":"T Yasukawa","year":"2005","unstructured":"Yasukawa T, et al. S-nitrosylation-dependent inactivation of Akt\/protein kinase B in insulin resistance. J Biol Chem. 2005;280(9):7511\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"1321_CR126","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1136\/gutjnl-2015-309272","volume":"65","author":"K Asanuma","year":"2016","unstructured":"Asanuma K, et al. In oesophageal squamous cells, nitric oxide causes S-nitrosylation of Akt and blocks SOX2 (sex determining region Y-box 2) expression. Gut. 2016;65(9):1416\u201326.","journal-title":"Gut"},{"issue":"5","key":"1321_CR127","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3892\/ijmm.2014.1920","volume":"34","author":"Y Chen","year":"2014","unstructured":"Chen Y, et al. Homocysteine reduces protein S-nitrosylation in endothelium. Int J Mol Med. 2014;34(5):1277\u201385.","journal-title":"Int J Mol Med"},{"issue":"12","key":"1321_CR128","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16(12):727\u201344.","journal-title":"Nat Rev Cardiol"},{"key":"1321_CR129","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.biopha.2018.01.145","volume":"99","author":"G Zhang","year":"2018","unstructured":"Zhang G, et al. Sex differences in the formation of atherosclerosis lesion in apoE(-\/-)mice and the effect of 17beta-estrodiol on protein S-nitrosylation. Biomed Pharmacother. 2018;99:1014\u201321.","journal-title":"Biomed Pharmacother"},{"key":"1321_CR130","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.biopha.2016.07.003","volume":"83","author":"Y Lin","year":"2016","unstructured":"Lin Y, et al. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation. Biomed Pharmacother. 2016;83:466\u201376.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1321_CR131","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1152\/physrev.00017.2011","volume":"92","author":"R Wang","year":"2012","unstructured":"Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev. 2012;92(2):791\u2013896.","journal-title":"Physiol Rev"},{"issue":"32","key":"1321_CR132","doi-asserted-by":"publisher","first-page":"19641","DOI":"10.1074\/jbc.M114.630111","volume":"290","author":"XH Liao","year":"2015","unstructured":"Liao XH, et al. STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin. J Biol Chem. 2015;290(32):19641\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"1321_CR133","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41598-017-02907-6","volume":"7","author":"XH Liao","year":"2017","unstructured":"Liao XH, et al. VEGF-A Stimulates STAT3 Activity via Nitrosylation of Myocardin to Regulate the Expression of Vascular Smooth Muscle Cell Differentiation Markers. Sci Rep. 2017;7(1):2660.","journal-title":"Sci Rep"},{"issue":"3","key":"1321_CR134","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jcp.1121","volume":"188","author":"A Ishida","year":"2001","unstructured":"Ishida A, et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188(3):359\u201368.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1321_CR135","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nm.2711","volume":"18","author":"S Wang","year":"2012","unstructured":"Wang S, et al. Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med. 2012;18(6):902\u201310.","journal-title":"Nat Med"},{"issue":"1","key":"1321_CR136","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cr.2014.150","volume":"25","author":"X Li","year":"2015","unstructured":"Li X, et al. Structural basis of AMPK regulation by adenine nucleotides and glycogen. Cell Res. 2015;25(1):50\u201366.","journal-title":"Cell Res"},{"issue":"1","key":"1321_CR137","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s44319-023-00015-3","volume":"25","author":"W Bai","year":"2024","unstructured":"Bai W, et al. S-nitrosylation of AMPKgamma impairs coronary collateral circulation and disrupts VSMC reprogramming. EMBO Rep. 2024;25(1):128\u201343.","journal-title":"EMBO Rep"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01321-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:32:21Z","timestamp":1757345541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01321-y","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"14 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animal or human subjects by the authors were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"78"}}